Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial

Simke Waijer; Sieta de Vries; Robert Busch; Di Xie; Ron Gansevoort; Fan Fan Hou; Jose Gorriz; Gozewijn Laverman; Luca De Nicola; Julio Pascual; Michele Provenzano; Pablo Pergola; Sydney Tang; Christoph Wanner; Philippe Zaoui; Hans-Henrik Parving; Dick de Zeeuw; Hiddo Heerspink

doi:10.1681/ASN.2021040498

Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial

Simke Waijer, Sieta de Vries, Robert Busch, Di Xie, Ron Gansevoort, Fan Fan Hou, Jose Gorriz, Gozewijn Laverman, Luca De Nicola, Julio Pascual, Michele Provenzano, Pablo Pergola, Sydney Tang, Christoph Wanner, Philippe Zaoui, Hans-Henrik Parving, Dick de Zeeuw, Hiddo Heerspink^*

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

7 Citaten (Scopus)

175 Downloads (Pure)

Samenvatting

n/a.

Originele taal-2	English
Pagina's (van-tot)	2731-2734
Aantal pagina's	4
Tijdschrift	Journal of the American Society of Nephrology
Volume	32
Nummer van het tijdschrift	11
Vroegere onlinedatum	20-aug.-2021
DOI's	https://doi.org/10.1681/ASN.2021040498
Status	Published - nov.-2021

Toegang tot document

10.1681/ASN.2021040498Licentie: Unspecified

Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR TrialFinal publisher's version, 614 KBLicentie: Unspecified

Handle.net

Permanente koppeling

Citeer dit

Waijer, S., de Vries, S., Busch, R., Xie, D., Gansevoort, R., Hou, F. F., Gorriz, J., Laverman, G., De Nicola, L., Pascual, J., Provenzano, M., Pergola, P., Tang, S., Wanner, C., Zaoui, P., Parving, H.-H., de Zeeuw, D., & Heerspink, H. (2021). Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial. Journal of the American Society of Nephrology, 32(11), 2731-2734. https://doi.org/10.1681/ASN.2021040498

@article{b9eb42c68f1242c6899c6c47195078f0,

title = "Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial",

abstract = "n/a.",

author = "Simke Waijer and {de Vries}, Sieta and Robert Busch and Di Xie and Ron Gansevoort and Hou, {Fan Fan} and Jose Gorriz and Gozewijn Laverman and {De Nicola}, Luca and Julio Pascual and Michele Provenzano and Pablo Pergola and Sydney Tang and Christoph Wanner and Philippe Zaoui and Hans-Henrik Parving and {de Zeeuw}, Dick and Hiddo Heerspink",

year = "2021",

month = nov,

doi = "10.1681/ASN.2021040498",

language = "English",

volume = "32",

pages = "2731--2734",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "AMER SOC NEPHROLOGY",

number = "11",

}

Waijer, S, de Vries, S, Busch, R, Xie, D, Gansevoort, R, Hou, FF, Gorriz, J, Laverman, G, De Nicola, L, Pascual, J, Provenzano, M, Pergola, P, Tang, S, Wanner, C, Zaoui, P, Parving, H-H, de Zeeuw, D & Heerspink, H 2021, 'Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial', Journal of the American Society of Nephrology, vol. 32, nr. 11, blz. 2731-2734. https://doi.org/10.1681/ASN.2021040498

TY - JOUR

T1 - Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial

AU - Waijer, Simke

AU - de Vries, Sieta

AU - Busch, Robert

AU - Xie, Di

AU - Gansevoort, Ron

AU - Hou, Fan Fan

AU - Gorriz, Jose

AU - Laverman, Gozewijn

AU - De Nicola, Luca

AU - Pascual, Julio

AU - Provenzano, Michele

AU - Pergola, Pablo

AU - Tang, Sydney

AU - Wanner, Christoph

AU - Zaoui, Philippe

AU - Parving, Hans-Henrik

AU - de Zeeuw, Dick

AU - Heerspink, Hiddo

PY - 2021/11

Y1 - 2021/11

N2 - n/a.

AB - n/a.

U2 - 10.1681/ASN.2021040498

DO - 10.1681/ASN.2021040498

M3 - Letter

C2 - 34417318

SN - 1046-6673

VL - 32

SP - 2731

EP - 2734

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 11

ER -

Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit